{"id":83094,"date":"2023-01-16T21:13:39","date_gmt":"2023-01-16T17:43:39","guid":{"rendered":"https:\/\/aprinpharmed.com\/pentixafor\/"},"modified":"2023-01-24T18:37:08","modified_gmt":"2023-01-24T15:07:08","slug":"pentixafor","status":"publish","type":"page","link":"https:\/\/aprinpharmed.com\/en\/pentixafor\/","title":{"rendered":"Pentixafor"},"content":{"rendered":"

[vc_row][vc_column]

Aprin Pharmed<\/div>
_<\/span>

Pentixafor<\/span><\/p>\n

 <\/p>\n

 <\/p>\n

CXCR4 is a type of receptor found in more than 30 types of cancer, including lymphoma, breast, pancreatic, ovarian, and lung cancer (SCLC). Basically, the chemokine receptor CXCR4 is considered a key factor for tumor growth and metastasis. 68Ga-PENTIXAFOR radiopharmaceutical is a new diagnostic radiopharmaceutical that intelligently identifies CXCR4 receptors and in this regard, the positron emission tomography (PET) method is used.<\/p>\n

\"\"<\/p>\n<\/div>_<\/span><\/div><\/div>[\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″]

CAS registration number<\/div><\/span>
  • <\/i><\/div>
    1341207-62-2<\/span><\/div><\/li><\/ul><\/div><\/div>
    Molecular weight<\/div><\/span>
    • <\/i><\/div>
      1221.384 g\/mol<\/span><\/div><\/li><\/ul><\/div><\/div>
      molecular formula<\/div><\/span>
      • <\/i><\/div>
        C60H80N14O14<\/span><\/div><\/li><\/ul><\/div><\/div>
        Appearance<\/div><\/span>
        • <\/i><\/div>
          Solid powder<\/span><\/div><\/li><\/ul><\/div><\/div>
          Maintenance<\/div><\/span>
          • <\/i><\/div>
            Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).<\/span><\/div><\/li><\/ul><\/div><\/div>
            Therapeutic applications<\/div><\/span>
            • <\/i><\/div>
              Positron Emission Tomography (PET) imaging or radionuclide therapy<\/span><\/div><\/li><\/ul><\/div><\/div><\/div><\/div>[\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"

              [vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row] … <\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-83094","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/aprinpharmed.com\/en\/wp-json\/wp\/v2\/pages\/83094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aprinpharmed.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/aprinpharmed.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/aprinpharmed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aprinpharmed.com\/en\/wp-json\/wp\/v2\/comments?post=83094"}],"version-history":[{"count":4,"href":"https:\/\/aprinpharmed.com\/en\/wp-json\/wp\/v2\/pages\/83094\/revisions"}],"predecessor-version":[{"id":83239,"href":"https:\/\/aprinpharmed.com\/en\/wp-json\/wp\/v2\/pages\/83094\/revisions\/83239"}],"wp:attachment":[{"href":"https:\/\/aprinpharmed.com\/en\/wp-json\/wp\/v2\/media?parent=83094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}